What caused this bullous eruption?
DOI:
https://doi.org/10.66344/jpad.15.2.2005.645References
Woodley DT, Briggaman RA, O'Keefe
EJ et al. Identification of the skin
basement-membrane autoantigen in
epidermolysis bullosa acquisita. N Engl
J Med 1984; 310: 1007-13.
Chan LS, Chen M, Woodley DT:
Epidermolysis bullosa acquisita in the
elderly: Clinical manifestations,
diagnosis and therapy. J Geriat
Dermatol 1996; 4: 47-52.
Jonkman MF, Schuur J, Dijk F et al.
Inflammatory variant of epidermolysis
bullosa acquisita with IgG
autoantibodies against type VII collagen
and laminin alpha3. Arch Dermatol
; 136: 227-31.
Kirtschig G, Murrell D, Wojnarowska F
et al. Interventions for mucous
membrane pemphigoid/cicatricial
pemphigoid and epidermolysis bullosa
acquisita: a systematic literature review.
Arch Dermatol 2002; 138: 380-4.
Sakai LY, Keene DR, Morris NP,
Burgeson RE. Type VII collagen is a
major structural component of
anchoring fibrils. J Cell Biol 1986; 103:
-86.
Yaoita H, Briggaman RA, Lawley TJ et
al. Epidermolysis bullosa acquisita:
ultrastructural and immunological
studies. J Invest Dermatol 1981; 76:
-92.
Boh E, Roberts LJ, Lieu TS et al.
Epidermolysis bullosa acquisita
preceding the development of systemic
lupus erythematosus. J Am Acad
Dermatol 1990; 22: 587-93.
Engineer L et al. Epidermolysis bullosa
acquisita and multiple myeloma. J Am
Acad Dermatol 2002; 47: 943-6.
Engineer L, Dow EC, Braverman IM,
Ahmed AR. Emerging treatment for
epidermolysis bullosa acquisita. J Am
Acad Dermatol 2001; 44:818-28.
Mutasim DF. Management of
autoimmune bullous diseases:
Pharmacology and therapeutics. J Am
Acad Dermatol 2004; 51: 859-77; quiz
-80.
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
